NCT07065773Phase 2Active not recruiting

Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis

Study sponsor: Vanda Pharmaceuticals

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2026-09Estimated
Enrollment · participants50Estimated
Source updated2026-02-04Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 2 fields changed

Primary completion date changed

− Before

Mar 2026

+ After

Sep 2026

Recruitment status changed

− Before

Recruiting

+ After

Active not recruiting

Check registry source